1. Kaplan SL, Grumbach MM. The ontogenesis of human foetal hormones. II. Luteinizing hormone (LH) and follicle stimulating hormone (FSH). Acta Endocrinol (Copenh) 1976;81:808-829.

2. Castillo RH, Matteri RL, Dumesic DA. Luteinizing hormone synthesis in cultured fetal human pituitary cells exposed to gonadotropin-releasing hormone. J Clin Endocrinol Metab 1992;75:318-322.

3. Sullivan KA, Silverman AJ. The ontogeny of gonadotropin-releasing hormone neurons in the chick. Neuroendocrinology 1993;58:597-608.

4. Apter D, Cacciatore B, Alfthan H, Stenman UH. Serum luteinizing hormone concentrations increase 100-fold in females from 7 years to adulthood, as measured by time-resolved immunofluorometric assay. J Clin Endocrinol Metab 1989;68:53-57.

5. Boyar RM, Rosenfeld RS, Kapen S, et al. Human puberty. Simultaneous augmented secretion of luteinizing hormone and testosterone during sleep. J Clin Invest 1974;54:609-618.

6. Ross JL, Loriaux DL, Cutler GB, Jr. Developmental changes in neuroendocrine regulation of gonadotropin secretion in gonadal dysgenesis. J Clin Endocrinol Metab 1983;57:288-293.

7. Spratt DI, O'Dea LS, Schoenfeld D, Butler J, Rao PN, Crowley WF, Jr. Neuroendocrine-gonadal axis in men: frequent sampling of LH, FSH, and testosterone. Am J Physiol 1988;254:E658-E666.

8. Dubey AK, Zeleznik AJ, Plant TM. In the rhesus monkey (Macaco, mulatta), the negative feedback regulation of follicle-stimulating hormone secretion by an action of testicular hormone directly at the level of the anterior pituitary gland cannot be accounted for by either testosterone or estradiol. Endocrinology 1987;121:2229-2237.

9. Illingworth PJ, Groome NP, Byrd W, et al. Inhibin-B: a likely candidate for the physiologically important form of inhibin in men. J Clin Endocrinol Metab 1996;81:1321-1325.

10. Anawalt BD, Bebb RA, Matsumoto AM, et al. Serum inhibin B levels reflect Sertoli cell function in normal men and men with testicular dysfunction. J Clin Endocrinol Metab 1996;81:3341-3345.

11. Nachtigall LB, Boepple PA, Seminara SB, et al. Inhibin B secretion in males with gonadotropin-releasing hormone (GnRH) deficiency before and during long-term GnRH replacement: relationship to spontaneous puberty, testicular volume, and prior treatment—a clinical research center study. J Clin Endocrinol Metab 1996;81:3520-3525.

12. Ying SY. Inhibins, activins, and follistatins: gonadal proteins modulating the secretion of follicle-stimulating hormone. Endocr Rev 1988;9:267-293.

13. Belchetz PE, Plant TM, Nakai Y, Keogh EJ, Knobil E. Hypophysial responses to continuous and intermittent delivery of hypothalamic gonadotropin-releasing hormone. Science 1978;202:631-633.

14. Seminara SB, Boepple PA, Nachtigall LB, et al. Inhibin B in males with gonadotropin-releasing hormone (GnRH) deficiency: changes in serum concentration after shortterm physiologic GnRH replace-ment—a clinical research center study. J Clin Endocrinol Metab 1996;81:3692-3696.

15. Hutson JM, Hasthorpe S, Heyns CF. Anatomical and functional aspects of testicular descent and cryptorchidism. Endocr Rev 1997;18:259-280.

16. Cortes D, Muller J, Skakkebaek NE. Proliferation of Sertoli cells during development of the human testis assessed by stereological methods. Int J Androl 1987;10:589-596.

17. Muller J, Skakkebaek NE. Quantification of germ cells and seminiferous tubules by stereological examination of testicles from 50 boys who suffered from sudden death. Int J Androl 1983;6:143-156.

18. Marshall GR, Plant TM. Puberty occurring either spontaneously or induced precociously in rhesus monkey (Macaca mulatta) is associated with a marked proliferation of Sertoli cells [published erratum appears in Biol Reprod 1996;55(3):728]. Biol Reprod 1996;54:1192-1199.

19. Rey R, Lordereau-Richard I, Carel JC, et al. Anti-mullerian hormone and testosterone serum levels are inversely during normal and precocious pubertal development. J Clin Endocrinol Metab 1993;77:1220-1226.

20. Russell LD, Bartke A, Goh JC. Postnatal development of the Sertoli cell barrier, tubular lumen, and cytoskeleton of Sertoli and myoid cells in the rat, and their relationship to tubular fluid secretion and flow. Am J Anat 1989;184:179-189.

21. Dym M, Cavicchia JC. Further observations on the blood-testis barrier in monkeys. Biol Reprod 1977;17:390-403.

22. Orth JM, Gunsalus GL, Lamperti AA. Evidence from Sertoli cell-depleted rats indicates that spermatid number in adults depends on numbers of Sertoli cells produced during perinatal development. Endocrinology 1988;122:787-794.

23. Russell LD, Peterson RN. Determination of the elongate spermatid-Sertoli cell ratio in various mammals. J Reprod Fertil 1984;70:635-641.

24. Russell LD, Ren HP, Sinha Hikim I, Schulze W, Sinha Hikim AP. A comparative study in twelve mammalian species of volume densities, volumes, and numerical densities of selected testis components, emphasizing those related to the Sertoli cell. Am J Anat 1990;188:21-30.

25. Orth JM. Proliferation of Sertoli cells in fetal and postnatal rats: a quantitative autoradiographic study. Anat Rev 1982;203:485-492.

26. Seminara SB, Acierno JS, Jr., Abdulwahid NA, Crowley WF, Jr., Margolin DH. Hypogonadotropic hypogonadism and cerebellar ataxia: detailed phenotypic characterization of a large, extended kindred. J Clin Endocrinol Metab 2002;87:1607-1612.

27. Kawai M, Momoi T, Fujii T, Nakano S, Itagaki Y, Mikawa H. The syndrome of Mobius sequence, peripheral neuropathy, and hypogonadotropic hypogonadism. Am J Med Genet 1990;37:578-582.

28. Vermeulen S, Messiaen L, Scheir P, De Bie S, Speleman F, De Paepe A. Kallmann syndrome in a patient with congenital spherocytosis and an interstitial 8p11.2 deletion. Am J Med Genet 2002;108:315-318.

29. Kallmann FJ, Schoenfeld WA. The genetic aspects of primary eunuchoidism. Am J Ment Defic 1944;158:203-236.

30. Zitzmann M, Nieschlag E. Hormone substitution in male hypogonadism. Mol Cell Endocrinol 2000;161:73-88.

31. Pitteloud N, Hayes FJ, Boepple PA, et al. The role of prior pubertal development, biochemical markers of testicular maturation, and genetics in elucidating the phenotypic heterogeneity of idiopathic hypog-onadotropic hypogonadism. J Clin Endocrinol Metab 2002;87:152-160.

32. Quinton R, Duke VM, Robertson A, et al. Idiopathic gonadotrophin deficiency: genetic questions addressed through phenotypic characterization. Clin Endocrinol (Oxf) 2001;55:163-174.

33. Conrad B, Kriebel J, Hetzel WD. Hereditary bimanual synkinesis combined with hypogonadotropic hypogonadism and anosmia in four brothers. J Neurol 1978;218:263-274.

34. Krams M, Quinton R, Ashburner J, et al. Kallmann's syndrome: mirror movements associated with bilateral corticospinal tract hypertrophy. Neurology 1999;52:816-822.

35. Kertzman C, Robinson DL, Sherins RJ, Schwankhaus JD, McClurkin JW. Abnormalities in visual spatial attention in men with mirror movements associated with isolated hypogonadotropic hypogonadism. Neurology 1990;40:1057-1063.

36. Kirk JMW, Grant DB, Besser GM, et al. Unilateral renal aplasia in X-linked Kallmann's syndrome. Clin Genet 1994;46:260-262.

37. Molsted K, Kjaer I, Giwercman A, Vesterhauge S, Skakkebaek NE. Craniofacial morphology in patients with Kallmann's syndrome with and without cleft lip and palate. Cleft Palate Craniofac J 1997;34:417-424.

38. Moorman JR, Crain B, Osborne D. Kallman's syndrome with associated cardiovascular and intracranial anomalies. Am J Med 1984;77:369-372.

39. Cortez AB, Galindo A, Arensman FW, Van Dop C. Congenital heart disease associated with sporadic Kallmann syndrome. Am J Med Genet 1993;46:551-554.

40. Filippi G. Klinefelter's syndrome in Sardinia. Clinical report of 265 hypogonadic males detected at the time of military check-up. Clin Genet 1986;30:276-284.

41. Waldstreicher J, Seminara SB, Jameson JL, et al. The genetic and clinical heterogeneity of gonadotropin-releasing hormone deficiency in the human. J Clin Endocrinol Metab 1996;81:4388-4395.

42. Main KM, Schmidt IM, Skakkebaek NE. A possible role for reproductive hormones in newborn boys: progressive hypogonadism without the postnatal testosterone peak. J Clin Endocrinol Metab 2000;85:4905-4907.

43. Huhtaniemi IT, Korenbrot CC, Jaffe RB. HCG binding and stimulation of testosterone biosynthesis in the human fetal testis. J Clin Endocrinol Metab 1977;44:963-967.

44. Graner J, Buchanan B, Abraira C. Ratio of arm span to height not usually increased in Klinefelter's syndrome. N Engl J Med 1982;306:1490-1491.

45. Reeves SL, Varakamin C, Henry CJ. The relationship between arm-span measurement and height with special reference to gender and ethnicity. Eur J Clin Nutr 1996;50:398-400.

46. Bardin CW, Ross GT, Rifkind AB, Cargille CM, Lipsett MB. Studies of the pituitary-Leydig cell axis in young men with hypogodotropic hypogonadism and hyposmia: comparison with normal men, pre-pubertal boys, and hypopituitary patients. J Clin Invest 1969;48:2046-2056.

47. Bin-Abbas B, Conte FA, Grumbach MM, Kaplan SL. Congenital hypogonadotropic hypogonadism and micropenis: effect of testosterone treatment on adult penile size why sex reversal is not indicated. J Pediatr 1999;34:579-583.

48. Lieblich JM, Rogol AD, White BJ, Rosen SW. Syndrome of anosmia with hypogonadotropic hypogonadism (Kallmann syndrome). Am J Med 1982;73:506-519.

49. McCullagh EP, Beck JC, Schaffenburg CA. A syndrome of eunuchoidism with spermatogenesis, normal urinary FSH and low or normal ICSH: "Fertile." Eunuchs. J Clin Endocrinol Metab 1953;13:489-509.

50. Smals AG, Kloppenborg PW, van Haelst UJ, Lequin R, Benraad TJ. Fertile eunuch syndrome versus classic hypogonadotrophic hypogonadism. Acta Endocrinol (Copenh) 1978;87:389-399.

51. Rogol AD, Mittal KK, White BJ, McGinniss MH, Lieblich JM, Rosen SW. HLA-compatible paternity in two "fertile eunuchs" with congenital hypogonadotropic hypogonadism and anosmia (the Kallman syndrome). J Clin Endocrinol Metab 1980;51:275-279.

52. Boyar RM, Wu RH, Kapen S, Hellman L, Weitzman ED, Finkelstein JW. Clinical and laboratory heterogeneity in idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 1976;43:1268-1275.

53. Pitteloud N, Boepple PA, DeCruz S, Valkenburgh SB, Crowley WF, Jr., Hayes FJ. The fertile eunuch variant of idiopathic hypogonadotropic hypogonadism: spontaneous reversal associated with a homozygous mutation in the gonadotropin-releasing hormone receptor. J Clin Endocrinol Metab 2001;86:2470-2475.

54. Styne DM. Puberty and its disorders in boys. Endocrinol Metab Clin North Am 1991;20:43-69.

55. Andersson AM, Muller J, Skakkebaek NE. Different roles of prepubertal and postpubertal germ cells and Sertoli cells in the regulation of serum inhibin B levels. J Clin Endocrinol Metab 1998;83:4451-4458.

56. Andersson AM, Juul A, Petersen JH, Muller J, Groome NP, Skakkebaek NE. Serum inhibin B in healthy pubertal and adolescent boys: relation to age, stage of puberty, and follicle-stimulating hormone, luteinizing hormone, testosterone, and estradiol levels. J Clin Endocrinol Metab 1997;82:3976-3981.

57. Tran D, Muesy-Dessole N, Josso N. Anti-Mullerian hormone is a functional marker of foetal Sertoli cells. Nature 1977;269:411-412.

58. Young J, Rey R, Couzinet B, Chanson P, Josso N, Schaison G. Antimullerian hormone in patients with hypogonadotropic hypogonadism. J Clin Endocrinol Metab 1999;84:2696-2699.

59. Lee MM, Donahoe PK, Hasegawa T, et al. Mullerian inhibiting substance in humans: normal levels from infancy to adulthood. J Clin Endocrinol Metab 1996;81:571-576.

60. Arimura A, Kastin AJ, Gonzales-Barcena D, Siller J, Weaver RE, Schally AV. Disappearance of LH-releasing hormone in man as determined by radioimmunoassay. 1974;3:421-425.

61. Pimstone B, Epstein S, Hamilton SM, LeRoith D, Hendricks S. Metabolic clearance and plasma half-disappearance time of exogenous gonadotropin-releasing hormone in normal subjects and in patients with liver disease and chronic renal failure. J Clin Endocrinol Metab 1977;44:356-360.

62. Clarke IJ, Cummins JT. The temporal relationship between gonadotropin-releasing hormone (GnRH) and luteinizing hormone (LH) secretion in ovariectomized ewes. Endocrinology 1982;111:1737-1739.

63. Levine JN, Pau KYF, Ramirez VD, Jackson GL. Simultaneous measurement of luteinizing hormone releasing hormone and luteinizing hormone release in unanesthetized, ovariectomized sheep. Endocrinology 1982;111:1449-1455.

64. Whitcomb RW, Crowley WF, Jr. Clinical review 4: diagnosis and treatment of isolated gonadotropin-releasing hormone deficiency in men. J Clin Endocrinol Metab 1990;70:3-7.

65. Spratt DI, Finkelstein JS, O'Dea LS, et al. Long-term administration of gonadotropin-releasing hormone in men with idiopathic hypogonadotropic hypogonadism. A model for studies of the hormone's physiologic effects. Ann Intern Med 1986;105:848-855.

66. Georgopoulos NA, Pralong FP, Seidman CE, Seidman JG, Crowley Jr WF, Vallejo M. Genetic heterogeneity evidenced by low incidence of KAL-1 gene mutations in sporadic cases of gonadotropin-releasing hormone deficiency. J Clin Endocrinol Metab 1997;82:213-217.

67. Bick D, Franco B, Sherins RJ, et al. Brief report: intragenic deletion of the KALIG-1 gene in Kallmann's syndrome [see comments]. N Engl J Med 1992;326:1752-1755.

68. de Roux N, Young J, Misrahi M, et al. A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor. N Engl J Med 1997;337:1597-1602.

69. Legouis R, Hardelin JP, Levilliers J, et al. The candidate gene for the X-linked Kallmann syndrome encodes a protein related to adhesion molecules. Cell 1991;67:423-435.

70. Jakacki RI, Kelch RP, Sauder SE, Lloyd JS, Hopwood NJ, Marshall JC. Pulsatile secretion of luteinizing hormone in children. J Clin Endocrinol Metab 1982;55:453-458.

71. Rugarli EI, Lutz B, Kuratani SC, et al. Expression pattern of the Kallmann syndrome gene in the olfactory system suggests a role in neuronal targeting. Nat Genet 1993;4:19-26.

72. Seminara SB, Hayes FJ, Crowley WF, Jr. Gonadotropin-releasing hormone deficiency in the human (idiopathic hypogonadotropic hypogonadism and Kallmann's syndrome): pathophysiological and genetic considerations. Endocr Rev 1998;19:521-539.

73. Oliveira LM, Seminara SB, Beranova M, et al. The importance of autosomal genes in Kallmann syndrome: genotype-phenotype correlations and neuroendocrine characteristics. J Clin Endocrinol Metab 2001;86:1532-1538.

74. Franco B, Guioli S, Pragliola A, et al. A gene deleted in Kallmann's syndrome shares homology with neural cell adhesion and axonal path-finding molecules. Nature 1991;353:529-536.

75. Quinton R, Duke VM, de Zoysa PA, et al. The neuroradiology of Kallmann's syndrome: a genotypic and phenotypic analysis. J Clin Endocrinol Metab 1996;81:3010-3017.

76. Hardelin JP, Levilliers J, Blanchard S, et al. Heterogeneity in the mutations responsible for X chromosome-linked Kallmann syndrome. Hum Mol Genet 1993;2:373-377.

77. Ballabio A, Carrozzo R, Parenti G, et al. Molecular heterogeneity of steroid sulfatase deficiency: a multicenter study on 57 unrelated patients, at DNA and protein levels. Genomics 1989;4:36-40.

78. Cohen-Salmon M, Tronche F, del Castillo I, Petit C. Characterization of the promoter of the human KAL gene, responsible for the X-chromosome-linked Kallmann syndrome. Gene 1995;164:235-242.

79. Hardelin JP, Levilliers J, Young J, et al. Xp22.3 deletions in isolated familial Kallmann's syndrome. J Clin Endocrinol Metab 1993;76:827-831.

80. Schwanzel-Fukuda M, Bick D, Pfaff DW. Luteinizing hormone-releasing hormone (LHRH)-express-ing cells do not migrate normally in an inherited hypogonadal (Kallmann) syndrome. Mol Brain Res 1989;6:311-326.

81. Parenti G, Rizzolo MG, Ghezzi M, et al. Variable penetrance of hypogonadism in a sibship with Kallmann syndrome due to a deletion of the KAL gene. Am J Med Genet 1995;57:476-478.

82. Zanaria E, Muscatelli F, Bardoni B, et al. An unusual member of the nuclear hormone receptor super-family responsible for X-linked adrenal hypoplasia congenita. Nature 1994;372:635-641.

83. Habiby RL, Boepple P, Nachtigall L, Sluss PM, Crowley WF, Jr., Jameson JL. Adrenal hypoplasia congenita with hypogonadotropic hypogonadism: evidence that DAX-1 mutations lead to combined hypo-thalmic and pituitary defects in gonadotropin production [see comments]. J Clin Invest 1996;98:1055-1062.

84. Merke DP, Tajima T, Baron J, Cutler GB, Jr. Hypogonadotropic hypogonadism in a female caused by an X-linked recessive mutation in the DAX1 gene. N Engl J Med 1999;340:1248-1252.

85. Caron P, Chauvin S, Christin-Maitre S, et al. Resistance of hypogonadic patients with mutated GnRH receptor genes to pulsatile GnRH administration. J Clin Endocrinol Metab 1999;84:990-996.

86. Tabarin A, Achermann JC, Recan D, et al. A novel mutation in DAX1 causes delayed-onset adrenal insufficiency and incomplete hypogonadotropic hypogonadism. J Clin Invest 2000;105:321-328.

87. Seminara SB, Achermann JC, Genel M, Jameson JL, Crowley WF, Jr. X-linked adrenal hypoplasia congenita: a mutation in DAX1 expands the phenotypic spectrum in males and females. J Clin Endocrinol Metab 1999;84:4501-4509.

88. Mason AJ, Pitts SL, Nikolics K, et al. The hypogonadal mouse: reproductive functions restored by gene therapy. Science 1986;234:1372-1378.

89. Layman LC, Wilson JT, Huey LO, Lanclos LD, Plouffe Jr L, McDonough PG. Gonadotropin-releasing hormone, follicle-stimulating hormone beta, luteinizing hormone beta gene structure in idiopathic hypogonadotropic hypogonadism. Fertil Steril 1992;57:42-49.

90. Nakayama Y, Wondisford FE, Lash RW, et al. Analysis of gonadotropin-releasing hormone gene structure in families with familial central precocious puberty and idiopathic hypogondotropic hypogo-nadism. J Clini Endocrinol Metab 1990;70:1233-1238.

91. Weiss J, Crowley WF, Jr., Jameson JL. Normal structure of the gonadotropin-releasing hormone (GnRH) gene in patients with GnRH deficiency and idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 1989;69:299-303.

92. de Roux N, Young J, Brailly-Tabard S, Misrahi M, Milgrom E, Schaison G. The same molecular defects of the gonadotropin-releasing hormone receptor determine a variable degree of hypogonadism in affected kindred. J Clin Endocrinol Metab 1999;84:567-572.

6 Male Hypogonadism Resulting From Mutations in the Genes for the Gonadotropin Subunits and Their Receptors

Was this article helpful?

0 0
Vanish Man Boobs

Vanish Man Boobs

Say goodbye to embarrassing man boobs forever. Thats right. Im going to share all of the research I collected and the cures I found with you. It is entirely possible to cure your man boobs forever without the use of drugs or surgery. Im going to show you how.

Get My Free Ebook

Post a comment